期刊文献+

关节炎患者血清及关节液白细胞介素6表达水平分析 被引量:8

Interleukin-6 levels in serum and synovial fluid in patients with arthritis
下载PDF
导出
摘要 目的 :比较白细胞介素 6 (IL - 6 )在几种不同类型关节炎患者血清及关节液中的表达水平 ,并探讨其在类风湿关节炎 (RA)发病中的作用及其与 RA病情活动的相关性。方法 :采用放射免疫分析法检测 RA、强直性脊柱炎、骨性关节炎、痛风等关节炎患者的血清和关节液中 IL - 6水平 ,并分析其与 RA病情活动的关系。结果 :RA患者的血清及关节液中 IL - 6的水平显著高于其他关节炎患者 ;且 RA患者关节液 IL - 6水平显著高于血清。RA患者血清 IL - 6水平与关节压痛数、关节肿胀数、 C-反应蛋白 (CRP)呈明显正相关 ;而关节液 IL - 6水平则与关节疼痛数、关节压痛数、关节肿胀数、血沉 (ESR)、 CRP呈明显正相关。结论 :IL - 6与 RA的发病有关 ,检测 RA患者关节液和血清中 IL - 6水平有助于 RA的诊断及判断病情的活动性。 Objective To compare the interleukin-6(IL-6) levels in patients with variety of arthritides and to evaluate the significance of IL-6 in the onset of rheumatoid arthritis(RA) and the correlation between IL-6 and RA disease activity. Methods The IL-6 levels in serum and synovial fluid in patients with RA, ankylosing spondylitis(AS), osteoarthritis(OA), and gouty arthritis were measured by radioimmunoassay, and the correlation between IL-6 and RA disease activity indicators was analyzed. Results The IL-6 levels both in serum and synovial fluid in RA patients was significantly higher than that in other kinds of arthritic patients, and the level of IL-6 in synovial fluid was significantly higher than that in serum in patients with RA. There were significant positive correlations between IL-6 level in serum and tender joint count, swollen joint count, and CRP as well as between IL-6 level in synovial fluid and pain joint count, tender joint count, swollen joint count, ESR, and CRP in patients with RA. Conclusion IL-6 is involved in the onset of RA and the determination of its level both in synovial fluid and serum in patients with RA is helpful for diagnosis of RA and estimating its disease activity.
出处 《吉林大学学报(医学版)》 CAS CSCD 北大核心 2004年第5期772-774,共3页 Journal of Jilin University:Medicine Edition
关键词 关节炎 关节炎 类风湿 白细胞介素6 arthritis arthritis, rheumatoid interleukin-6
  • 相关文献

参考文献8

  • 1祝威,汪欣,杜宝东.杀菌-通透性增强蛋白对分泌性中耳炎大鼠中耳黏膜TNF-α和IL-6表达的影响[J].吉林大学学报(医学版),2004,30(1):41-44. 被引量:17
  • 2[3]Wendling D,Racadot E, Wijdenes J. Treatment of severe rheumatoid arthritis by anti-interleukin-6 monoclonal antibody[J]. J Rheumal, 1993,20:259-262.
  • 3[4]Yoshida K, Kobayashi K, Yamagata N, et al. Inflammatory cytokines and enzymes in synovial fluid of patients with rheumatoid arthritis and other arthritis[J]. Int Arch Allergy Immunol, 1992,98(4):286-292.
  • 4[5]Ito A, Itoh Y, Sasaguri Y, et al. Effects of interleukin-6 on the metabolism of connective tissue components in rheumatoid synovial fibroblasts[J]. Arthritis Rheum, 1992,35(10):1197-1201.
  • 5[6]Jikko A, Wakisaka T, Iwamoto M, et al. Effects of interleukin-6 on proliferation and proteoglycan metabolism in articular chondrocyte cultures[J]. Cell Biol Int, 1998,22(9-10):615-621.
  • 6[7]Barrera P, Boerbooms AM, Janssen EM,et al. Circulating soluble tumor necrosis factor receptors, interleukin-2 receptors, tumor necrosis factor alpha, and interleukin-6 levels in rheumatoid arthritis. Longitudinal evaluation during methotrexate and azathioprine therapy[J]. Arthritis Rheum, 1993,36(8):1070-1079.
  • 7[8]Gratacos J, Collado A, Pons F, et al. Significant loss of bone mass in patients with early, active ankylosing spondylitis: a follow up study[J]. Arthritis Rheum, 1999,42(11):2319-2324.
  • 8[9]Punzi L, Calo L, Plebani M. Clinical significance of cytokine determination in synovial fluid[J]. Crit Rev Clin Lab Sci, 2002,39(1):63-88.

二级参考文献1

共引文献16

同被引文献73

引证文献8

二级引证文献107

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部